Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma

Gastroenterology

Volumn 118, Issue 6, 2000, Pages 1018-1024

  Lewis, James D ^a,b   Schwartz, J Sanford ^a,b   Lichtenstein, Gary R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ARTICLE; CROHN DISEASE; DECISION THEORY; HUMAN; MAINTENANCE THERAPY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; REMISSION; TREATMENT OUTCOME;

EID: 0034075584     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70353-2     Document Type: Article

References (35)

1. EV Loftus Jr MD Silverstein WJ Sandborn WJ Tremaine WS Harmsen AR Zinsmeister Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival Gastroenterology 114 1998 1161 1168
2. DK Podolsky Inflammatory bowel disease (part 1) N Engl J Med 325 1991 928 937
3. J George DH Present R Pou C Bodian PH Rubin The long-term outcome of ulcerative colitis treated with 6-mercaptopurine Am J Gastroenterol 91 1996 1711 1714
4. DC Pearson GR May GH Fick LR Sutherland Azathioprine and 6-mercaptopurine in Crohn's disease. A metaanalysis Ann Intern Med 123 1995 132 142
5. MA Peppercom 6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come Am J Gastroenterol 91 1996 1689 1690
6. WJ Sandborn A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 91 1996 423 433
7. AH Wilkinson JL Smith LG Hunsicker J Tobacman DP Kapelanski M Johnson FH Wright DM Behrendt RJ Corr y Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone Transplantation 47 1989 293 296
8. AJ Silman J Petrie B Hazleman SJ Evans Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study Ann Rheum Dis 47 1988 988 992
9. G Opelz R Henderson Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 1993 1514 1516
10. LJ Kinlen Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 1985 44 49
11. P Asten J Marrett D Symmons Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases J Rheumatol 26 1999 1705 1714
12. DH Present SJ Meltzer MP Krumholz A Wolke BI Korelitz 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity Ann Intern Med 111 1989 641 649
13. WR Connell MA Kamm M Dickson AM Balkwill JK Ritchie JE Lennard-Jones Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease Lancet 343 1994 1249 1252
14. Y Bouhnik M Lemann JY Mary G Scemama R Tai C Matuchansky R Modigliani JC Rambaud Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine Lancet 347 1996 215 219
15. A Gelb R Zalusky The use of azathioprine and 6-mercaptopurine (6-MP) as immunosuppressive therapy in inflammatory bowel disease and its role in the etiology of lymphocytic lymphoma [letter] Am J Gastroenterol 78 1983 316
16. L Larvol JC Soule A Le Tourneau Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease [letter] N Engl J Med 331 1994 883 884
17. AJ Greenstein R Gennuso DB Sachar T Heimann H Smith HD Janowitz AH Aufses Jr Extraintestinal cancers in inflammatory bowel disease Cancer 56 1985 2914 2921
18. A Ekbom C Helmick M Zack HO Adami Extracolonic malignancies in inflammatory bowel disease Cancer 67 1991 2015 2019
19. JF Fielding P Prior JA Waterhouse WT Cooke Malignancy in Crohn's disease Scand J Gastroenterol 7 1972 3 7
20. SN Gyde P Prior JC Macartney H Thompson JA Waterhouse RN Allan Malignancy in Crohn's disease Gut 21 1980 1024 1029
21. PG Persson P Karlen O Bernell CE Leijonmarck O Brostrom A Ahlbom G Hellers Crohn's disease and cancer: a population-based cohort study Gastroenterology 107 1994 1675 1679
22. PI Pitt AH Sultan M Malone V Andrews EB Hamilton Association between azathioprine therapy and lymphoma in rheumatoid disease J R Soc Med 80 1987 428 429
23. J Gregor W McDonald N Klar R Wall K Atkinson B Lamba B Feagan An evaluation of utility measures in Crohn's disease Inflamm Bowel Dis 3 1997 265 276
24. CA Uyl-de Groot A Hagenbeek LF Verdonck B Lowenberg FF Rutten Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL) Bone Marrow Transplant 16 1995 463 470
25. SR Targan SB Hanauer SJ van Deventer L Mayer DH Present T Braakman KL DeWoody TF Schaible PJ Rutgeerts A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group N Engl J Med 337 1997 1029 1035
26. DH Present P Rutgeerts S Targan SB Hanauer L Mayer RA van Hogezand DK Podolsky BE Sands T Braakman KL DeWoody TF Schaible SJ van Deventer Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 1999 1398 1405
27. JC Wright MC. Weinstein Gains in life expectancy from medical interventions—standardizing data on outcomes N Engl J Med 339 1998 380 386
28. SEER Cancer Statistics Review 1973-1995 LAG Ries CL Kosary BF Hankey BA Miller BK Edwards 1998 National Cancer Institute Bethesda, MD
29. V Binder C Hendriksen S. Kreiner Prognosis in Crohn's disease— based on results from a regional patient group from the county of Copenhagen Gut 26 1985 146 150
30. HS Mekhjian DM Switz CS Melnyk GB Rankin RK Brooks Clinical features and natural history of Crohn's disease Gastroenterology 77 1979 898 906
31. M Silverstein E Loftus W Sandborn W Tremaine B Feagan P Nietert W Harmsen A Zinsmeister Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort Gastroenterology 117 1999 49 57
32. P Munkholm E Langholz M Davidsen V Binder Intestinal cancer risk and mortality in patients with Crohn's disease Gastroenterology 105 1993 1716 1723
33. H Andrews P Lewis R Allan Mortality in Crohn's disease: a clinical analysis Q J Med 71 1989 399 405
34. IT Weterman I Biemond AS Pena Mortality and causes of death in Crohn's disease. Review of 50 years' experience in Leiden University Hospital Gut 31 1990 1387 1390
35. S Ventura K Peters J Martin J Maurer Births and deaths: United States, 1996 1996 National Center for Health Statistics Hyattsville, MD